CFA
ABBV icon

Camarda Financial Advisors’s AbbVie ABBV Stock Holding History

Camarda Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,742
Closed -$2.52M – 97
2024
Q3 		$2.52M Buy
+12,742
New +$2.38M 0.94% 34
2020
Q4 		– Sell
-14,099
Closed -$1.24M – 66
2020
Q3 		$1.24M Hold
14,099
– – 1.5% 17
2020
Q2 		$1.38M Buy
+14,099
New +$1.24M 1.94% 14
2019
Q3 		– Sell
-399
Closed -$29K – 34
2019
Q2 		$29K Sell
399
-172
-30% -$13.5K 0.06% 109
2019
Q1 		$46K Buy
571
+138
+32% +$11.3K 0.09% 81
2018
Q4 		$40K Sell
433
-16
-4% -$1.41K 0.05% 88
2018
Q3 		$42K Hold
449
– – 0.05% 116
2018
Q2 		$42K Hold
449
– – 0.04% 113
2018
Q1 		$42K Sell
449
-2,012
-82% -$221K 0.04% 103
2017
Q4 		$238K Buy
2,461
+63
+3% +$5.94K 0.28% 63
2017
Q3 		$213K Sell
2,398
-110
-4% -$8.37K 0.23% 74
2017
Q2 		$182K Buy
2,508
+391
+18% +$26.3K 0.19% 76
2017
Q1 		$138K Sell
2,117
-4,681
-69% -$294K 0.13% 85
2016
Q4 		$426K Buy
6,798
+567
+9% +$34.6K 0.29% 82
2016
Q3 		$393K Buy
6,231
+668
+12% +$43.2K 0.24% 84
2016
Q2 		$344K Buy
5,563
+692
+14% +$42.2K 0.22% 81
2016
Q1 		$278K Buy
+4,871
New +$271K 0.17% 93
2015
Q3 		– Sell
-1,095
Closed -$74K – 165
2015
Q2 		$74K Buy
+1,095
New +$71.5K 0.04% 117
2013
Q3 		– Sell
-35
Closed -$1K – 97
2013
Q2 		$1K Buy
+35
New +$1.53K ﹤0.01% 260

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Camarda Financial Advisors's ABBV Position: Q4 2024 in Review

Camarda Financial Advisors sold out of AbbVie (ABBV) in Q4 2024, closing a stake of 12,742 shares — an estimated $2.52M sold.

Camarda Financial Advisors first reported a position in ABBV in Q2 2013 and held it in 19 quarters. The position peaked at $2.52M in Q3 2024. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Camarda Financial Advisors reported no remaining AbbVie position as of Q4 2024 after selling out during the quarter.
  • Camarda Financial Advisors sold 12,742 AbbVie shares in Q4 2024, an estimated $2.52M.
  • Camarda Financial Advisors first reported a position in AbbVie in Q2 2013 and held it in 19 quarters.
  • Camarda Financial Advisors's AbbVie position peaked at $2.52M in Q3 2024.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Camarda Financial Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.